Mayo Clinic health news articles

Whole genome breast cancer study launched by Mayo Clinic USA
The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.

Skin cancer melanoma rising in young adults
Even as the rates of some cancers are falling, Mayo Clinic is seeing an alarming trend: the dramatic rise of skin cancer, especially among people under 40. The incidence of melanoma has escalated, and young women are the hardest hit.

Regorafenib improves survival of colorectal cancer patients
Regorafenib - an investigational drug - slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer. This is the first novel agent in eight years to show improvement in overall survival of colon cancer patients who have run out of treatment options.

HER growth proteins do not predict outcome of herceptin treatment breast cancer patients
Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient's outcome after treatment for HER2 Positive Breast Cancer with Herceptin, say Mayo Clinic researchers.

PSA test helps predicting biopsy need and low risk prostate cancer
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released during a meeting of the North Central Section of the American Urological Association in Rancho Mirage, California, US.

Children with multiple surgeries before age 2 develop a learning disability
36.6 percent children who had multiple surgeries before age 2 developed a learning disability later in life, but it should not alter decision-making related to surgery in young children. The new study examines children experiencing anesthesia and surgeries under age 2.

Advanced stage prostate cancer patients experience 20 year survival rates with surgery
Long-term survival rates for patients with advanced prostate cancer suggest they can be good candidates for surgery, Mayo Clinic researchers have found. Their study found a 20-year survival rate for 80 percent of patients diagnosed with cancer that has potentially spread beyond the prostate, known as cT3 prostate cancer, and treated with radical prostatectomy, or surgery to remove the prostate gland.

Herceptin with chemotherapy improves breast cancer survival
Using Herceptin with chemotherapy clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher.

Vitamin D supplements might help lymphoma patients
A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression and overall survival.

Anesthesia during delivery does not affect learning in baby
Children exposed to anesthesia during Cesarean section are not at any higher risk for learning disabilities later in life than children not delivered by C-section, revealed by researchers.

New iPS therapy pioneered for heart attacks
Induced pluripotent stem (iPS) cells can be used to treat heart disease, revealed by researchers at Mayo Clinic, USA. iPS cells are stem cells converted from adult cells.

Exercise helps stroke patients recover faster
A person who has exercised regularly prior to the onset of a stroke appears to recover more quickly, say researchers from Mayo Clinic in Florida, USA, in the Journal of Neurology, Neurosurgery & Psychiatry.

Structural MRI may diagnose dementia patients accurately
Researchers developed STAND-Map - a framework for MRI-based differential diagnosis of three common neurodegenerative disorders: Alzheimer's disease, frontotemporal lobar degeneration, and Lewy body disease using Structural MRI.

Celiac disease incidence rising in US
In US, Celiac disease is over four times more common today than it was 50 years ago, revealed by researchers at Mayo Clinic. The study is published in the journal Gastroenterology.

Success with ipilimumab in prostate cancer patients
Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy.

Bariatric surgery increases fracture risk
Persons who undergo bariatric surgery may have a greater chance of experiencing broken bones, especially in their hands and feet, revealed by researchers at Mayo Clinic.

Green tea shows promise in leukemia
Mayo Clinic researchers are reporting positive results in early leukemia clinical trials using the chemical epigallocatechin gallate (EGCG), an active ingredient in green tea.

Triple drug combination promising to treat breast cancer
Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.

Hormone therapy reduces woman's risk of colorectal cancer by 40%
In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal cancer risk. However, the mechanisms for the apparent protective association are still unclear.

Mayo Clinic Health Manager powered by Microsoft HealthVault
Mayo Clinic and Microsoft Corp. announced the launch of Mayo Clinic Health Manager, a privacy- and security-enhanced free online application that provides people with a place to store medical information and receive real-time individualized health guidance and recommendations based on the clinical expertise of Mayo Clinic.

Cardiac imaging exams have radiation risks
At the radiation dose levels used in cardiac imaging exams, such as cardiac CT or nuclear medicine scans, the risk of potentially harmful effects from ionizing radiation are low. However, since the exact level of risk is not known, people without symptoms of heart disease should think twice about seeking, or agreeing to, these types of cardiac studies.

Rheumatoid arthritis rising among women in US
After four decades on the decline, rheumatoid arthritis is on the upswing among women in the United States. That's the finding presented by Mayo Clinic investigators at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals in San Francisco.

Heart disease rising in US after 2000
A Mayo Clinic analysis of two decades of autopsy results shows a long-term decline in the prevalence of coronary disease has ended and the disease may be on the upswing. The findings appear in today's issue of Archives of Internal Medicine.

Health news organizations - M

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
4.33